CC BY-NC-ND 4.0 · Arquivos Brasileiros de Neurocirurgia: Brazilian Neurosurgery 2018; 37(01): 19-26
DOI: 10.1055/s-0038-1639588
Original Article | Artigo Original
Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

Profile of Patients with Intracranial Tumors Undergoing Surgical Resection at a Neuro-oncology Referral Hospital

Perfil dos pacientes com tumores intracranianos submetidos a ressecção cirúrgica em um hospital de referência neuro-oncológica
Marcelo Lemos Vieira da Cunha
1   Neurosurgery, Hospital Regional do Oeste, Chapecó, SC, Brazil
,
Luiza Grosbelli
2   Universidade Comunitária da Região de Chapecó (UNOCHAPECÓ), Chapecó, SC, Brazil
› Author Affiliations
Further Information

Publication History

24 July 2017

09 February 2018

Publication Date:
27 March 2018 (online)

Abstract

Objectives To analyze the epidemiological aspects of primary and metastatic tumors of the central nervous system (CNS) among patients operated on by a single surgeon dedicated to neuro-oncology at Hospital Regional do Oeste, in Chapecó (Santa Catarina, Brazil), between 2013 and 2016.

Methods Cross-sectional, retrospective, and observational analysis of 347 patients undergoing surgery due to intracranial tumors. The patients' data were obtained from the hospital registry, medical records, and pathology reports.

Results Primary CNS tumors comprised 72.1% of the sample. There was a predominance of females (52.7%), and the mean age was 49.3 years, with a peak of incidence between the ages of 25 and 64 years. Gliomas were the most common primary brain tumors (23.7%), followed by meningiomas (17.0%). Lung cancer (15.3%), breast cancer (4.9%), and melanoma (3.5%) were, in descending order, the most frequent primary sites of metastases, which were recorded in 97 cases (27.9%).

Conclusion The lack of standardization in the process of notification of tumor diseases imposes challenges in the establishment of estimates close to the real ones, preventing improvement of public health care policies to protect patients with neuro-oncological conditions. Based on the current model, regionalization of the data seems to be the best option in the management of this subgroup of patients.

Resumo

Objetivos Analisar aspectos epidemiológicos dos tumores cerebrais primários e metastáticos entre os pacientes operados por um único cirurgião dedicado à neuro-oncologia no Hospital Regional do Oeste, em Chapecó, SC, Brasil, durante os anos de 2013 a 2016.

Métodos Estudo transversal, retrospectivo, do tipo observacional, com análise de 347 casos de neoplasias intracranianas de acordo com os dados obtidos no setor de registro hospitalar, nos prontuários da instituição e registros anatomopatológicos dos pacientes tratados cirurgicamente.

Resultados Tumores cerebrais primários corresponderam a 72.1% da amostra. Houve predomínio do sexo feminino (52,7%) e a média de idade foi de 49,3 anos, com pico de incidência na faixa etária de 25 a 64 anos. Gliomas foram os tumores cerebrais primários mais encontrados (23.7%), seguidos por meningiomas (17,0%). Cânceres de pulmão (15,3%), mama (4,9%) e melanoma (3,5%) foram, em ordem decrescente, as localizações primárias mais frequentes das metástases registradas em 97 casos (27.9%).

Conclusão A dificuldade em se estabelecer uma estimativa mais próxima da realidade devido à falta de padronização na notificação de agravos tumorais impede uma melhor condução de políticas públicas de amparo ao paciente neuro-oncológico. Assim, nos moldes atuais, a regionalização dos dados parece a melhor opção na administração desse subgrupo de pacientes.

 
  • References

  • 1 El-Zein R, Minn AY, Wrensch M, Bondy ML. Epidemiology of brain tumors. In: Levin VA. , ed. Cancer in the nervous system. 2ed. New York: Oxford University Press; 2002: 252-266
  • 2 Samuels MA. Manual of neurology: diagnosis and treatment. 9th ed. LWW: Baltimore; 2007
  • 3 Ministry of Health. National Cancer Institute José Alencar Gomes da Silva. Estimate 2016 - Incidence of cancer in Brazil. Rio de Janeiro: INCA; 2017
  • 4 Cambruzzi E, Zettler CG, Zettler EW, Jotz GP, Grudzinski M, Pedrini J. Immunohistochemical profile of central nervous system metástases. Rev AMRIGS 2009; 53 (04) 382-387
  • 5 Baldi I, Gruber A, Alioum A. , et al; Gironde TSNC Registry Group. Descriptive epidemiology of CNS tumors in France: results from the Gironde Registry for the period 2000-2007. Neuro-oncol 2011; 13 (12) 1370-1378
  • 6 Dolecek TA, Propp JM, Stroup NE, Kruchko C. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro-oncol 2012; 14 (Suppl. 05) v1-v49
  • 7 Gomes JC, Sá A, Pinto RR, Muñoz V, Coelho C, Monsanto F. Radiosurgical treatment of brain metastases: the relation of histology, brain location and symptoms. Health Tech 2012; 7 (01) 28-32
  • 8 Onishi FJ, Melo JGSP, Melo PMP, Lanzoni OP, Settanni F, Ferraz FAP. Surgical treatment of intracranial metastases. Rev Neurosci 2005; 13 (01) 11-16
  • 9 Santos AJ, Franco CMR, Borges LRR, Malheiros SMF, Gabbai AA. Brain metastases. Rev Neurosci 2001; 9 (01) 20-26
  • 10 Maldaun MVC. Radiosurgery in the treatment of brain metastases: therapeutic response and complications based on lesion location [thesis]. São Paulo: Faculty of Medicine, Universidade de São Paulo; 2006
  • 11 McDermott MW, Sneed PK. Radiosurgery in metastatic brain cancer. Neurosurgery 2005; 57 (5, Suppl) S45-S53 , S1–S4
  • 12 Louis DN, Ohgaki H, Wiestler OD. , et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114 (02) 97-109
  • 13 Davis DL, Ahlbom A, Hoel D, Percy C, Schwartz J. Is brain cancer mortality increasing in industrial countries?. Am J Ind Med 1991; 19 (04) 421-431
  • 14 Greig NH, Ries LG, Yancik R, Rapoport SI. Increasing annual incidence of primary malignant brain tumors in the elderly. J Natl Cancer Inst 1990; 82 (20) 1621-1624
  • 15 Modan B, Wagener DK, Feldman JJ, Rosenberg HM, Feinleib M. Increased mortality from brain tumors: a combined outcome of diagnostic technology and change of attitude toward the elderly. Am J Epidemiol 1992; 135 (12) 1349-1357
  • 16 Porter KR, McCarthy BJ, Freels S, Kim Y, Davis FG. Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology. Neuro-oncol 2010; 12 (06) 520-527
  • 17 Kohler BA, Ward E, McCarthy BJ. , et al. Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst 2011; 103 (09) 714-736
  • 18 Claus EB, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M, Black PM. Epidemiology of intracranial meningioma. Neurosurgery 2005; 57 (06) 1088-1095 , discussion 1088–1095
  • 19 McKinley BP, Michalek AM, Fenstermaker RA, Plunkett RJ. The impact of age and sex on the incidence of glial tumors in New York state from 1976 to 1995. J Neurosurg 2000; 93 (06) 932-939
  • 20 Inskip PD, Linet MS, Heineman EF. Etiology of brain tumors in adults. Epidemiol Rev 1995; 17 (02) 382-414
  • 21 Velema JP, Walker AM. The age curve of nervous system tumour incidence in adults: common shape but changing levels by sex, race and geographical location. Int J Epidemiol 1987; 16 (02) 177-183
  • 22 Central Brain Tumor Registry of the United States. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2004–2008. 2012. Disponível em: http://www.cbtrus.org
  • 23 Wöhrer A, Waldhör T, Heinzl H. , et al. The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry. J Neurooncol 2009; 95 (03) 401-411
  • 24 Rockhill J, Mrugala M, Chamberlain MC. Intracranial meningiomas: an overview of diagnosis and treatment. Neurosurg Focus 2007; 23 (04) E1
  • 25 Barnholtz-Sloan JS, Kruchko C. Meningiomas: causes and risk factors. Neurosurg Focus 2007; 23 (04) E2
  • 26 Correa C, Soares MS, Cabrera HTN, Figueiredo EG, Teixeira MJ. Gliomas: surgical casuistry in a hospital-quaternary school. Arq Bras Neurocir 2011; 30 (01) 34-37
  • 27 Santos R, Frigeri L, Ordovás C. , et al. Epidemiology of tumors of the central nervous system, Our Lady of Pompei Hospital, Neurosurgery Service, about 100 cases studied. Rev Cient AMECS 2001; 10 (01) 24-32
  • 28 Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M. Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol 2006; 2 (09) 494-503 , quiz 1, 516
  • 29 Davis FG, Kupelian V, Freels S, McCarthy B, Surawicz T. Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. Neuro-oncol 2001; 3 (03) 152-158
  • 30 Deorah S, Lynch CF, Sibenaller ZA, Ryken TC. Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001. Neurosurg Focus 2006; 20 (04) E1
  • 31 Pereira ELR, Rodrigues DB, Viegas MLC, Hermes Junior MN, Burbano RMR. Epidemiology of gliomas in state of Pará – Part I (2000–2006). Arq Bras Neurocir 2012; 31 (04) 200-206
  • 32 Kleihues P, Cavenee WK. Tumors of the central nervous system: pathology and genetics. Lyon: International Agency for Research on Cancer; 1997
  • 33 Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol 2005; 109 (01) 93-108
  • 34 Melmed S. Update in pituitary disease. J Clin Endocrinol Metab 2008; 93 (02) 331-338
  • 35 Goel A, Nadkarni T, Muzumdar D, Desai K, Phalke U, Sharma P. Giant pituitary tumors: a study based on surgical treatment of 118 cases. Surg Neurol 2004; 61 (05) 436-445 , discussion 445–446
  • 36 Sheehan J, Kondziolka D, Flickinger J, Lunsford LD. Radiosurgery for patients with recurrent small cell lung carcinoma metastatic to the brain: outcomes and prognostic factors. J Neurosurg 2005; 102 (Suppl): 247-254
  • 37 Gavrilovic IT, Posner JB. Brain metastases: epidemiology and pathophysiology. J Neurooncol 2005; 75 (01) 5-14
  • 38 Schuette W. Treatment of brain metastases from lung cancer: chemotherapy. Lung Cancer 2004; 45 (Suppl. 02) S253-S257
  • 39 Maldaun MVC, Pires de Aguiar PH, Zambelli HJL, Sawaya R. Surgical treatment of brain metastases. J Bras Neurosurg 2006; 17 (01) 14-19
  • 40 Patchell RA. Metastatic brain tumors. In: Brain tumors in adults. Black PM, Wen PY. (eds.). WB Saunnders Company; 1995: 95-99
  • 41 Thapar K, Laws ER. Tumors of the Central Nervous System. In: Clinical Oncology. Murphy GP, Lawrence W. (eds.). American Cancer Society; 1995: 424-462
  • 42 Deangelis LM, Loeffler JS, Mamelak AN. . Primary brain tumors. Cancer management. A multidisciplinary approach. 8th ed. 2004
  • 43 Correia J, Alexandre JC, Dias C. , et al. Glioblastoma Multiforme – A purpose of a clinical case. J Portuguese Soc Int Med 2009; 16 (01) 27-32
  • 44 Posner JB. Intracranial metastases. In: Neurologic complications of cancer. Posner JB. (ed.). FA Davis Company; 1995: 77-110
  • 45 Davey P. Brain metastases. Curr Probl Cancer 1999; 23 (02) 59-98
  • 46 Patchell RA, Tibbs PA, Walsh JW. , et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990; 322 (08) 494-500
  • 47 Vecht CJ, Haaxma-Reiche H, Noordijk EM. , et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?. Ann Neurol 1993; 33 (06) 583-590
  • 48 Pan HC, Sheehan J, Stroila M, Steiner M, Steiner L. Gamma knife surgery for brain metastases from lung cancer. J Neurosurg 2005; 102 (Suppl): 128-133
  • 49 Kamada K, Mastuo T, Tani M. , et al. Effects of stereotactic radiosurgery on metastatic brain tumors of various histopathologies. Neuropathology 2001; 21 (04) 307-314
  • 50 Bajard A, Westeel V, Dubiez A. , et al. Multivariate analysis of factors predictive of brain metastases in localised non-small cell lung carcinoma. Lung Cancer 2004; 45 (03) 317-323
  • 51 Burt M, Wronski M, Arbit E, Galicich JH. ; Memorial Sloan-Kettering Cancer Center Thoracic Surgical Staff. Resection of brain metastases from non-small-cell lung carcinoma. Results of therapy. J Thorac Cardiovasc Surg 1992; 103 (03) 399-410 , discussion 410–411
  • 52 Hernandez L, Zamorano L, Sloan A. , et al. Gamma knife radiosurgery for renal cell carcinoma brain metastases. J Neurosurg 2002; 97 (5, Suppl) 489-493
  • 53 Hoshi S, Jokura H, Nakamura H. , et al. Gamma-knife radiosurgery for brain metastasis of renal cell carcinoma: results in 42 patients. Int J Urol 2002; 9 (11) 618-625 , discussion 626, author reply 627
  • 54 Sheehan JP, Sun MH, Kondziolka D, Flickinger J, Lunsford LD. Radiosurgery in patients with renal cell carcinoma metastasis to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control. J Neurosurg 2003; 98 (02) 342-349
  • 55 Mystakidou K, Kouloulias V, Tsilika E. , et al. Is early recognition of radiologically silent brain metastasis from breast cancer beneficial? A retrospective study of 22 cases. Breast Cancer 2004; 11 (03) 276-281
  • 56 Slimane K, Andre F, Delaloge S. , et al. Risk factors for brain relapse in patients with metastatic breast cancer. Ann Oncol 2004; 15 (11) 1640-1644
  • 57 Atallah E, Flaherty L. Treatment of metastatic malignant melanoma. Curr Treat Options Oncol 2005; 6 (03) 185-193
  • 58 Daryanani D, Plukker JT, de Jong MA. , et al. Increased incidence of brain metastases in cutaneous head and neck melanoma. Melanoma Res 2005; 15 (02) 119-124
  • 59 Sampson JH, Carter Jr JH, Friedman AH, Seigler HF. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg 1998; 88 (01) 11-20
  • 60 Sawaya R, Ligon BL, Bindal AK, Bindal RK, Hess KR. Surgical treatment of metastatic brain tumors. J Neurooncol 1996; 27 (03) 269-277
  • 61 Ghods AJ, Munoz L, Byrne R. Surgical treatment of cerebellar metastases. Surg Neurol Int 2011; 2: 159